Pfizer's VELSIPITY® Receives European Commission Approval

Pfizer Inc. has announced that the European Commission (EC) has granted marketing authorization for VELSIPITY® (etrasimod) in the European Union, marki...

February 20, 2024 | Tuesday | News
Roche Diagnostics and BioPorto Announce Expanded Collaboration

    ProNephro AKI (NGAL) stands out as the first AKI biomarker test to secure FDA clearance for pediatric use, covering children from...

February 20, 2024 | Tuesday | News
Bayer AG and AskBio Initiate Phase II Trial of AB-1002 Gene Therapy for Congestive Heart Failure

Bayer AG and Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, announ...

February 19, 2024 | Monday | News
Vidac Pharma's VDA-1275 Shows Promising Efficacy Across Solid Tumor Models and Enhances Standard Treatments

Vidac Pharma Holdings Plc. (Hamburg and Stuttgart: T9G; ISIN:GB00BM9XQ619; WKN: A3DTUQ), a pioneering oncology biopharmaceutical company, has revealed prom...

February 19, 2024 | Monday | News
CMR Surgical Appoints Industry Veteran to Lead Operations in Asia Pacific, Middle East, and Africa

CMR Surgical (CMR), a global leader in surgical robotics, has announced the appointment of Sushobhan Dasgupta as President and Chief Commercial Officer for...

February 19, 2024 | Monday | News
Vetter Pioneers Market Launch of Eight Innovative Drug Products in 2023

Vetter, a globally recognized contract development and manufacturing organization (CDMO), proudly announces the successful market introduction of eight cus...

February 14, 2024 | Wednesday | News
Exscientia Dismisses CEO Andrew Hopkins Over Inappropriate Relationships

Exscientia plc (Nasdaq: EXAI), a frontrunner in AI-driven precision medicine, has officially announced a significant leadership adjustment and the submissi...

February 14, 2024 | Wednesday | News
Roche Collaborates with PathAI to Enhance Digital Pathology Capabilities for Companion Diagnostics

PathAI will exclusively work with Roche Tissue Diagnostics (RTD) to develop artificial intelligence (AI) digital pathology algorithms for RTD's companion...

February 13, 2024 | Tuesday | News
Curasight Announces Accelerated Basket Trial Targeting Five Cancer Indications

Curasight A/S ("Curasight" or the "Company" (XSAT: CURAS) is forging ahead with its mission to revolutionize cancer treatment, announcing today the acceler...

February 13, 2024 | Tuesday | News
Biovian and 3P Biopharmaceuticals Form 3PBIOVIAN, a Pan-European Biologics Powerhouse

Backed by their common shareholder, Keensight Capital, one of the leading private equity funds dedicated to pan-European Growth Buyout[] investments, the c...

February 02, 2024 | Friday | News
Carcinotech Secures $5.3M Funding to Boost Global Expansion of Carcino3D Technology

Carcinotech has raised $5.3 million of funding as the company looks to build on its traction in the UK and Europe, with US expansion planned later this yea...

January 31, 2024 | Wednesday | News
Sandoz Introduces Tyruko® Biosimilar for MS, a Milestone in Germany

Tyruko® approved for all indications of reference medicine  Tyruko® biosimilar to treat adults with highly active relapsing remitting multi...

January 31, 2024 | Wednesday | News
Qubit Pharma, Institut Curie, and University of Bordeaux Collaborate on Innovative Cancer Therapies

The three partners are joining forces to develop drug candidates that modulate the immune response of cancer patients and block the development of metast...

January 30, 2024 | Tuesday | News
RevoluGen and LGC Biosearch Showcase Advanced DNA Extraction with Fire Monkey Chemistry

Under a collaboration with LGC Biosearch TechnologiesTM, RevoluGen has coupled its Fire Monkey chemistry with LGC magnetic beads and LGC oKtopureTM liquid ...

January 30, 2024 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close